GE Aerospace (NYSE:GE) reported fourth-quarter results that cleared Wall Street’s bar and signaled a robust 2026, as the world’s leading jet-engine maker converts a massive $190 billion backlog into high-margin service revenue.
Plus Therapeutics (NASDAQ:PSTV) on Thursday detailed a strategic shift toward "pivotal trial readiness," supported by a recently completed $15 million public offering designed to extend the company’s cash runway into 2027.
Cass Information Systems (NASDAQ:CASS) capped off a historic 2025 with record annual net income, as the St. Louis-based payment processor successfully leveraged higher interest rates to offset a persistent slump in the transportation sector.
Freeport-McMoRan (NYSE:FCX) reported fourth-quarter adjusted earnings that sailed past Wall Street forecasts, proving that record-high metal prices can insulate the world’s largest publicly traded copper producer from even severe operational disruptions.